Microdosing LSD Fails to Ease ADHD Symptoms in Small Trial

[ad_1]

(MedPage Today) — Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity disorder (ADHD) in adults, a double-blind randomized phase IIa trial showed.
After 6 weeks, the group who…

[ad_2]

Source link : https://www.medpagetoday.com/psychiatry/adhd-add/114735

Author :

Publish date : 2025-03-19 19:28:00

Copyright for syndicated content belongs to the linked Source.